Researchers validated a Japanese version of the ATTARI-12 scale to measure medical trainees' attitudes toward AI in healthcare.
Key Details
- 1The J-ATTARI-12 scale was developed and validated based on a nationwide survey of 326 Japanese medical students and residents.
- 2The scale assesses two dimensions: 'AI anxiety and aversion' and 'AI optimism and acceptance.'
- 3Psychometric evaluation showed good validity, reliability, and model fit.
- 4The tool enables structured assessment of readiness, concerns, and acceptance of AI in medical training.
- 5J-ATTARI-12 will be used in a new 'Medicine and AI' program at Juntendo University from 2026.
- 6Published in JMIR Medical Education on January 14, 2026.
Why It Matters
Understanding medical trainees’ attitudes toward AI is critical for effective curriculum development and the responsible integration of AI into clinical practice. The J-ATTARI-12 scale provides a culturally adapted tool to identify barriers and support the future workforce in adopting AI, including in radiology.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.